Nexstim Oyj
OMXH:NXTMH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nexstim Oyj
OMXH:NXTMH
|
FI |
|
Asahi India Glass Ltd
NSE:ASAHIINDIA
|
IN |
|
Zodiac Clothing Company Ltd
NSE:ZODIACLOTH
|
IN |
|
EIH Ltd
NSE:EIHOTEL
|
IN |
|
20 Microns Ltd
NSE:20MICRONS
|
IN |
|
C
|
Chiyoda Ute Co Ltd
TSE:5387
|
JP |
|
N
|
Naturel Yenilenebilir Enerji Ticaret AS
IST:NATEN.E
|
TR |
|
Xvivo Perfusion AB
STO:XVIVO
|
SE |
|
G
|
GITI Tire Corp
SSE:600182
|
CN |
|
V
|
Viva China Holdings Ltd
HKEX:8032
|
HK |
|
Mory Industries Inc
TSE:5464
|
JP |
|
V
|
Vantage Towers AG
XHAM:VTWR
|
DE |
|
A
|
Alphabet Inc
XETRA:ABEA
|
US |
|
Beijing Huafeng Test & Control Technology Co Ltd
SSE:688200
|
CN |
|
Solar Industries India Ltd
NSE:SOLARINDS
|
IN |
|
Netac Technology Co Ltd
SZSE:300042
|
CN |
|
Bakkavor Group Plc
LSE:BAKK
|
UK |
Nexstim Oyj
Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
